INSUBCONTINENT EXCLUSIVE:
A joint China-Singapore research team is using nanoparticle technology to create a cancer vaccine that has produced promising results in
animal tests – reducing the regrowth and spread of tumours up to seven times more effectively than existing treatments.
The nanovaccine
attacks not only regular cancerous cells but also cancer stem cells (CSCs), which can lie dormant within tumours during treatment, only
awakening when conditions are more favourable to the disease.
The bioinspired approach...
